Pfizer Lines Up Trio Of US Biosimilar Launches

Bevacizumab, Rituximab And Trastuzumab Slated For US Entry

 
• By Aidan Fry
  
Toy_Cars
Pfizer expects within the next few months to bring three biosimilars to the US market • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products